An artificial intelligence (AI)-enabled digital stethoscope, combined with an electrocardiogram (EKG) based screening, has shown promise in detecting peripartum cardiomyopathy in pregnant and recently pregnant women. The technology, which uses an AI algorithm, demonstrated twice the detection rate compared to standard obstetric care, including clinical EKGs. Peripartum cardiomyopathy is a type of heart failure affecting women late in pregnancy or after childbirth. The AI-guided screening utilized a digital stethoscope to record electrical activity and heart sounds. The study, involving nearly 1,200 Nigerian women, suggests that AI-assisted screening could provide a proactive and cost-effective approach to identify pregnancy-related cardiac dysfunction, facilitating early diagnosis and management. The American Heart Association's scientific meetings' statements and conclusions are solely those of the study authors and do not necessarily reflect the Association's policy or position.
An artificial intelligence (AI)-enabled digital stethoscope, combined with an electrocardiogram (EKG) based screening, has shown promise in detecting peripartum cardiomyopathy in pregnant and recently pregnant women. The technology, which uses an AI algorithm, demonstrated twice the detection rate compared to standard obstetric care, including clinical EKGs. Peripartum cardiomyopathy is a type of heart failure affecting women late in pregnancy or after childbirth. The AI-guided screening utilized a digital stethoscope to record electrical activity and heart sounds. The study, involving nearly 1,200 Nigerian women, suggests that AI-assisted screening could provide a proactive and cost-effective approach to identify pregnancy-related cardiac dysfunction, facilitating early diagnosis and management. The American Heart Association's scientific meetings' statements and conclusions are solely those of the study authors and do not necessarily reflect the Association's policy or position.